Home » AMCP Plans Biosimilar Database To Monitor Safety and Efficacy
AMCP Plans Biosimilar Database To Monitor Safety and Efficacy
The Academy of Managed Care Pharmacy plans to develop a virtual data network that documents safety and efficacy information on biosimilars and could possibly be used to identify safety signals for those drugs. The industry association has established a biosimilars task force, comprised of industry and regulatory stakeholders, to tackle the design and development of the network, dubbed the Biosimilars Collective Intelligence System.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May